Daratumumab-based induction therapy for multiple myeloma: A systematic review and meta-analysis.
Crit Rev Oncol Hematol. 2021 Mar;159:103211. doi: 10.1016/j.critrevonc.2020.103211. Epub 2020 Dec 30.
Crit Rev Oncol Hematol. 2021.
PMID: 33387628
Review.